BioMarin Pharmaceutical Inc. (BMRN) was downgraded from Buy to Hold on Monday, November 1st---a negative sign for the stock that investors will have to endure. FYI, Morgan Joseph uses the following rating scale when analyzing stocks: Buy, Hold, Sell.
BioMarin Pharmaceutical Inc. has an average analyst recommendation score of 2 and competes for investment dollars withAmgen Inc. (AMGN) and Talecris Biotherapeutics Holdings Corp. (TLCR) --two other stocks in the Biotechnology industry that have average analyst recommendation scores of 1.9 and 2.8, respectively.
BioMarin Pharmaceutical Inc. has an average analyst recommendation score of 2 and competes for investment dollars withAmgen Inc. (AMGN) and Talecris Biotherapeutics Holdings Corp. (TLCR) --two other stocks in the Biotechnology industry that have average analyst recommendation scores of 1.9 and 2.8, respectively.
No comments:
Post a Comment